Traveka Wealth, LLC Astrazeneca PLC Transaction History
Traveka Wealth, LLC
- $224 Billion
- Q3 2025
A detailed history of Traveka Wealth, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Traveka Wealth, LLC holds 6,840 shares of AZN stock, worth $611,496. This represents 0.23% of its overall portfolio holdings.
Number of Shares
6,840
Previous 5,366
27.47%
Holding current value
$611,496
Previous $375 Million
39.95%
% of portfolio
0.23%
Previous 0.2%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...